Admission glucose, HbA1c levels and inflammatory cytokines in patients with acute ST-elevation myocardial infarction

Leonidou L, Mouzaki A, Michalaki M, DeLastic AL, Kyriazopoulou V, Bassaris HP, Gogos CA. Cytokine production and hospital mortality in patients with sepsis-induced stress hyperglycemia. J Infect. 2007;55:340–6. https://doi.org/10.1016/j.jinf.2007.05.177

Article  PubMed  Google Scholar 

McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17:107–24. https://doi.org/10.1016/s0749-0704(05)70154-8

Article  CAS  PubMed  Google Scholar 

Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 2004;30:748–56. https://doi.org/10.1007/s00134-004-2167-y

Article  PubMed  Google Scholar 

Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004;53:2079–86. https://doi.org/10.2337/diabetes.53.8.2079

Article  CAS  PubMed  Google Scholar 

Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067–72. https://doi.org/10.1161/01.cir.0000034509.14906.ae

Article  CAS  PubMed  Google Scholar 

Angeli F, Reboldi G, Poltronieri C, Lazzari L, Sordi M, Garofoli M, et al. Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications. Ther Adv Cardiovasc Dis. 2015;9:412–24. https://doi.org/10.1177/1753944715594528

Article  CAS  PubMed  Google Scholar 

Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–8. https://doi.org/10.1016/S0140-6736(99)08415-9

Article  CAS  PubMed  Google Scholar 

Cheng S-Y, Wang H, Lin S-H, Wen J-H, Ma L-L, Dai X-C. Association of admission hyperglycemia and all-cause mortality in acute myocardial infarction with percutaneous coronary intervention: a dose-response meta-analysis. Front Cardiovasc Med. 2022;9:932716. https://doi.org/10.3389/fcvm.2022.932716

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dziewierz A, Giszterowicz D, Siudak Z, Rakowski T, Dubiel JS, Dudek D. Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction. Clin Res Cardiol. 2010;99:715–21. https://doi.org/10.1007/s00392-010-0175-1

Article  PubMed  Google Scholar 

Li D, Hua Q, Guo J, Li H, Chen H, Zhao S. Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with ST-elevation acute myocardial infarction. Intern Med. 2011;50:2471–5. https://doi.org/10.2169/internalmedicine.50.5750

Article  CAS  PubMed  Google Scholar 

Schmitz T, Freuer D, Harmel E, Heier M, Peters A, Linseisen J, Meisinger C. Prognostic value of stress hyperglycemia ratio on short- and long-term mortality after acute myocardial infarction. Acta Diabetol. 2022;59:1019–29. https://doi.org/10.1007/s00592-022-01893-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meisinger C, Hörmann A, Heier M, Kuch B, Löwel H. Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era. Int J Cardiol. 2006;113:229–35. https://doi.org/10.1016/j.ijcard.2005.11.018

Article  PubMed  Google Scholar 

Butkowski EG, Jelinek HF. Hyperglycaemia, oxidative stress and inflammatory markers. Redox Rep. 2017;22:257–64. https://doi.org/10.1080/13510002.2016.1215643

Article  CAS  PubMed  Google Scholar 

Liu N, Sheng J, Wang Y. Effect of stress hyperglycaemia on monocyte chemoattractant protein-1 levels and the short-term prognosis of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Exp Ther Med. 2019;17:3823–9. https://doi.org/10.3892/etm.2019.7338

Article  CAS  PubMed  PubMed Central  Google Scholar 

Löwel H, Meisinger C, Heier M, Hörmann A. The population-based acute myocardial infarction (AMI) registry of the MONICA/KORA study region of Augsburg. Gesundheitswesen. 2005;67(Suppl 1):S31–7. https://doi.org/10.1055/s-2005-858241

Article  PubMed  Google Scholar 

Kuch B, Heier M, von Scheidt W, Kling B, Hoermann A, Meisinger C. 20-year trends in clinical characteristics, therapy and short-term prognosis in acute myocardial infarction according to presenting electrocardiogram: the MONICA/KORA AMI Registry (1985–2004). J Intern Med. 2008;264:254–64. https://doi.org/10.1111/j.1365-2796.2008.01956.x

Article  CAS  PubMed  Google Scholar 

Olink Proteomics. Normalized protein eXpression. https://www.olink.com/faq/what-is-npx/

Ponce-de-Leon M, Linseisen J, Peters A, Linkohr B, Heier M, Grallert H, et al. Novel associations between inflammation-related proteins and adiposity: a targeted proteomics approach across four population-based studies. Transl Res. 2022;242:93–104. https://doi.org/10.1016/j.trsl.2021.11.004

Article  CAS  PubMed  Google Scholar 

Szczepańska E, Gietka-Czernel M. FGF21: a Novel Regulator of glucose and lipid metabolism and whole-body Energy Balance. Horm Metab Res. 2022;54:203–11. https://doi.org/10.1055/a-1778-4159

Article  CAS  PubMed  Google Scholar 

Schmitz T, Harmel E, Heier M, Peters A, Linseisen J, Meisinger C. Inflammatory plasma proteins predict short-term mortality in patients with an acute myocardial infarction. J Transl Med. 2022;20:457. https://doi.org/10.1186/s12967-022-03644-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haybar H, Bandar B, Torfi E, Mohebbi A, Saki N. Cytokines and their role in cardiovascular diseases. Cytokine. 2023;169:156261. https://doi.org/10.1016/j.cyto.2023.156261

Article  CAS  PubMed  Google Scholar 

Zietz B, Büchler C, Herfarth H, Müller-Ladner U, Spiegel D, Schölmerich J, Schäffler A. Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the– 2518 A–G promoter polymorphism. Diabetes Obes Metab. 2005;7:570–8. https://doi.org/10.1111/j.1463-1326.2004.00436.x

Article  CAS  PubMed  Google Scholar 

Simeoni E, Hoffmann MM, Winkelmann BR, Ruiz J, Fleury S, Boehm BO, et al. Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and type 2 diabetes mellitus. Diabetologia. 2004;47:1574–80. https://doi.org/10.1007/s00125-004-1494-4

Article  CAS  PubMed  Google Scholar 

Whelan CD, Mattsson N, Nagle MW, Vijayaraghavan S, Hyde C, Janelidze S, et al. Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease. Acta Neuropathol Commun. 2019;7:169. https://doi.org/10.1186/s40478-019-0795-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fineschi S, Klar J, Gustafsson KA, Jonsson K, Karlsson B, Dahl N. Inflammation and Interferon Signatures in Peripheral B-Lymphocytes and Sera of individuals with Fibromyalgia. Front Immunol. 2022;13:874490. https://doi.org/10.3389/fimmu.2022.874490

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aversa J, Song M, Shimazu T, Inoue M, Charvat H, Yamaji T, et al. Prediagnostic circulating inflammation biomarkers and esophageal squamous cell carcinoma: a case-cohort study in Japan. Int J Cancer. 2020;147:686–91. https://doi.org/10.1002/ijc.32763

Article  CAS  PubMed  Google Scholar 

Isvoran A, Peng Y, Ceauranu S, Schmidt L, Nicot AB, Miteva MA. Pharmacogenetics of human sulfotransferases and impact of amino acid exchange on phase II drug metabolism. Drug Discov Today. 2022;27:103349. https://doi.org/10.1016/j.drudis.2022.103349

Article  CAS  PubMed  Google Sc

Comments (0)

No login
gif